Full length α-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects

被引:305
|
作者
Borghi, R
Marchese, R
Negro, A
Marinelli, L
Forloni, G
Zaccheo, D
Abbruzzese, G
Tabaton, M
机构
[1] Univ Genoa, Dept Expt Med, Inst Human Anat, I-16132 Genoa, Italy
[2] Univ Genoa, Dept Neurosci, I-16132 Genoa, Italy
[3] Univ Padua, Dept Biol Chem, I-35100 Padua, Italy
[4] Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy
关键词
alpha-synuclein; Parkinson's disease; cerebrospinal fluid; neurodegenerative diseases; biological markers;
D O I
10.1016/S0304-3940(00)01153-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Several clues suggest that alpha-synuclein, a presynaptic protein, plays a central role in the pathogenesis of idiopathic Parkinson's disease (PD). To search a peripheral marker of PD, we analyzed presence and amount of alpha-synuclein in CSF from 12 PD patients and 10 neurologically normal subjects. The protein was extracted from CSF samples through immunoprecipitation and immunoblotting with different specific anti-alpha-synuclein antibodies. We identified a 19 kDa band that corresponds to monomeric alpha-synuclein, given its comigration with homologue human recombinant peptide as well as with the protein extracted from cerebral cortex of normal subjects. The amount of CSF 19 kDa alpha-synuclein did not significantly vary in PD and normal cases. These findings have two implications: (a) full length alpha-synuclein is released by neurons in the extracellular space; (b) alpha-synuclein does not appear a peripheral marker of PD pathology. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:65 / 67
页数:3
相关论文
共 50 条
  • [21] Normal cerebrospinal fluid levels of insulin in patients with Parkinson's disease
    F. J. Jiménez-Jiménez
    J. A. Molina
    C. Vargas
    P. Gómez
    F. de Bustos
    M. Zurdo
    C. Gómez-Escalonilla
    B. Barcenilla
    A. Berbel
    A. Camacho
    J. Arenas
    Journal of Neural Transmission, 2000, 107 : 445 - 449
  • [22] Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects
    Toledo, Jon B.
    Zetterberg, Henrik
    van Harten, Argonde C.
    Glodzik, Lidia
    Martinez-Lage, Pablo
    Bocchio-Chiavetto, Luisella
    Rami, Lorena
    Hansson, Oskar
    Sperling, Reisa
    Engelborghs, Sebastiaan
    Osorio, Ricardo S.
    Vanderstichele, Hugo
    Vandijck, Manu
    Hampel, Harald
    Teipl, Stefan
    Moghekar, Abhay
    Albert, Marilyn
    Hu, William T.
    Argiles, Jose A. Monge
    Gorostidi, Ana
    Teunissen, Charlotte E.
    De Deyn, Peter P.
    Hyman, Bradley T.
    Molinuevo, Jose L.
    Frisoni, Giovanni B.
    Linazasoro, Gurutz
    de Leon, Mony J.
    van der Flier, Wiesje M.
    Scheltens, Philip
    Blennow, Kaj
    Shaw, Leslie M.
    Trojanowski, John Q.
    BRAIN, 2015, 138 : 2701 - 2715
  • [23] β-synuclein in cerebrospinal fluid as a potential biomarker for distinguishing human prion diseases from Alzheimer’s and Parkinson’s disease
    Bing Xu
    Kang Xiao
    Xiaoxi Jia
    Rundong Cao
    Donglin Liang
    Ruhan A
    Weiwei Zhang
    Chunjie Li
    Liping Gao
    Cao Chen
    Qi Shi
    Xiaoping Dong
    Alzheimer's Research & Therapy, 17 (1)
  • [24] α-synuclein-lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson's disease patients
    Paslawski, Wojciech
    Zareba-Paslawska, Justyna
    Zhang, Xiaoqun
    Holzl, Katharina
    Wadensten, Henrik
    Shariatgorji, Mohammadreza
    Janelidze, Shorena
    Hansson, Oskar
    Forsgren, Lars
    Andren, Per E.
    Svenningsson, Per
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (30) : 15226 - 15235
  • [25] Clearing Extracellular Alpha-Synuclein from Cerebrospinal Fluid: A New Therapeutic Strategy in Parkinson's Disease
    Menendez-Gonzalez, Manuel
    Padilla-Zambrano, Huber S.
    Tomas-Zapico, Cristina
    Fernandez Garcia, Benjamin
    BRAIN SCIENCES, 2018, 8 (04):
  • [26] Conformational change of a-synuclein fibrils in cerebrospinal fluid from different clinical phases of Parkinson's disease
    Fan, Yun
    Sun, Yunpeng
    Yu, Wenbo
    Tao, Youqi
    Xia, Wencheng
    Liu, Yiqi
    Zhao, Qinyue
    Tang, Yilin
    Sun, Yimin
    Liu, Fengtao
    Cao, Qin
    Wu, Jianjun
    Liu, Cong
    Wang, Jian
    Li, Dan
    STRUCTURE, 2023, 31 (01) : 78 - +
  • [27] α-Synuclein Deposition in the Colon and Premotor Markers of Parkinson's disease in Neurologically Normal Subjects
    Kim, Joong-Seok
    Kim, Su-Young
    Kang, Won-Kyung
    NEUROLOGY, 2016, 86
  • [28] Comparative study of cerebrospinal fluid α-synuclein seeding aggregation assays for diagnosis of Parkinson's disease
    Kang, Un Jung
    Boehme, Amelia K.
    Fairfoul, Graham
    Shahnawaz, Mohammad
    Ma, Thong Chi
    Hutten, Samantha J.
    Green, Alison
    Soto, Claudio
    MOVEMENT DISORDERS, 2019, 34 (04) : 536 - 544
  • [29] Increase of α-synuclein oligomer in cerebrospinal fluid of the drug-naive patients with Parkinson's disease
    Park, M. J.
    Bae, H. -J.
    Cheon, S. -M.
    Kim, J. W.
    MOVEMENT DISORDERS, 2010, 25 (07) : S410 - S410
  • [30] Plasma α-synuclein is decreased in subjects with Parkinson's disease
    Li, Qiao-Xin
    Mok, Su San
    Laughton, Katrina M.
    McLean, Catriona A.
    Cappai, Roberto
    Masters, Colin L.
    Culvenor, Janetta G.
    Horne, Malcolm K.
    EXPERIMENTAL NEUROLOGY, 2007, 204 (02) : 583 - 588